Find a Tender
Record
Official procurement procedure
Aseptically Prepared Dosebanded Medicines 2022
Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: HealthTrust Europe LLP (HTE) Acting On Behalf of University Hospital Coventry and Warwickshire: "Aseptically Prepared Dosebanded Medicines 2022". Published status: awardUpdate. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | HealthTrust Europe LLP (HTE) Acting On Behalf of University Hospital Coventry and Warwickshire | Scope & Categories | Not published | Submission Window | Recorded No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: HealthTrust Europe LLP (HTE) Acting On Behalf of University Hospital Coventry and Warwickshire
Market Analytics
Derived from OCDS awards & bid statistics
Published history for HealthTrust Europe LLP (HTE) Acting On Behalf of University Hospital Coventry and Warwickshire. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
Not availableNo published reports
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 1 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
StatusNot published | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published30 Jul 2026, 07:17 BST | Last source update30 Jul 2026, 07:17 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-0308cd | ||
What is being bought
No description published
What changed
From the official release history
- Status changed to published status
30 Jul 2026, 07:17 BST - Official notice release published
30 Jul 2026, 07:17 BST - Buyer information updated
30 Jul 2026, 07:17 BST - tender value changed
13 Jul 2022, 09:18 BST - Status changed to complete
13 Jul 2022, 09:18 BST - Official notice release published
13 Jul 2022, 09:18 BST - Submission deadline changed to published date
13 Jul 2022, 09:18 BST - Published value updated to £3,500,000,000
7 Jan 2022, 22:45 GMT - Status changed to active
7 Jan 2022, 22:45 GMT - Official notice release published
7 Jan 2022, 22:45 GMT - Submission deadline changed to 14 Feb 2022, 12:00 GMT
7 Jan 2022, 22:45 GMT - Buyer information updated
7 Jan 2022, 22:45 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedHTE established a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti cancer chemotherapy drugs in ready to administer presentations and agreed dose bands. The framework agreement covers the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses are based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
30 Jul 2026, 07:17 BST - Award active
Not published · Not published - Contract active
Signed 13 Jul 2022, 00:00 BST · £3,500,000,000
Commercial outcome and competition
Awards BAXTER HEALTHCARE LIMITED, Healthcare at Home Ltd, Qualasept Ltd t/a Bath ASU, Quantum Pharmaceutical Not published · Not published · active |
Contracts Aseptically Prepared Dosebanded Medicines 2022 £3,500,000,000 · signed 13 Jul 2022, 00:00 BST · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
HealthTrust Europe LLP (HTE) Acting On Behalf of University Hospital Coventry and Warwickshire
Contracting authority GB-FTS-185348Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published